News

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature...

David Aranda, a neurodivergent researcher on GRIB'S Group, talks to us about how his structured way of thinking has become key asset to advance...

Marta Espinosa presented the article "Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort" during...

This September, a European project led by the Universitat Pompeu Fabra and where GRIB participates has been launched which aims to replace a quarter...

The new edition of the ranking, which has just been published, includes 41 researchers who have worked at Hospital de Mar and the Research...

VICT3R is a new IHI-funded initiative aiming to revolutionize nonclinical safety testing by significantly reducing animal use in toxicology research....

Dr. Miguel ángel Mayer contributed to the CIOMS report on Real World Data and Real World Evidence, guiding regulators on using this data. ...

The G-protein-coupled receptor-based drug development group, led by Jana Selent, creates molecular dynamics simulations that help find new drugs for nervous system diseases....

Prof. Joseph Schacherer from the University of Strasbourg has done a seminar: "Species-wide quantitative transcriptomes and proteomes reveal distinct genetic control of gene expression variation"...